ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

159 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q3 2021.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,379,501 shares of 27,767,902 outstanding shares and own 69.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,595,053 shares), FARALLON CAPITAL MANAGEMENT LLC (1,995,000 shares), ARMISTICE CAPITAL, LLC (1,836,000 shares), VANGUARD GROUP INC (1,800,363 shares), STATE STREET CORP (1,072,182 shares), FIRST MANHATTAN CO (969,736 shares), NORTHERN TRUST CORP (959,048 shares), Krensavage Asset Management, LLC (936,777 shares), RENAISSANCE TECHNOLOGIES LLC (756,585 shares), and DIMENSIONAL FUND ADVISORS LP (610,866 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.